BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, May 5, 2025
Home
»
Topics
»
Regulatory
» NMPA
NMPA
RSS
China Food and Drug Administration accepts clinical trial application for sirotinib
July 16, 2015
Phase II trials of F-351 begin in China
June 12, 2015
Arteether amine maleate cleared to enter clinical studies in China
May 26, 2015
China FDA clears IND for development of DP-VPA through phase III for epilepsy
April 16, 2015
China approves Epidaza for peripheral T-cell lymphoma
Jan. 13, 2015
Sirnaomics files Chinese IND application for STP-705 for hypertrophic scars
Jan. 7, 2015
China publishes draft biosimilar guidance
Nov. 18, 2014
DC Bead approved in China for tumor embolization
Aug. 28, 2014
UC MSCs show potential in clinical study for SLE
July 30, 2014
China's regulatory authority approves phase II trials of F-351
July 3, 2014
Previous
1
2
…
45
46
47
48
49
50
51
52
53
Next